William Steere - Zoetis Independent Director

<div class='circular--portrait' style='background:#2A0CD0;color: white;font-size:3em;padding-top: 35px;;'>ZTS</div>
ZTS -- USA Stock  

Earning Report: February 13, 2020  

  Director
Mr. William C. Steere, Jr. is Independent Director of the Company. Mr. Steere joined Pfizer in 1959 and held various positions, including Chief Executive Officer from 1991 until 2000, Chairman of the board of directors from 1992 until 2001, and member of the board of directors until 2011. Mr. Steere also served on the boards of Dow Jones Company, Inc. until 2007 MetLife, Inc. until 2010 and Health Management Associates, Inc. until 2014. Mr. Steeres business and senior management experience, his public company board experience and his knowledge of the animal health business obtained through his service with Pfizer make him a valuable member of our Board.
Age: 81  Director Since 2013      
973 822-7000  www.zoetis.com

Management Efficiency

The company has 6.66 B in debt with debt to equity (D/E) ratio of 248.5 . This implies that the company may be unable to create cash to meet all of its financial commitments. Zoetis has Current Ratio of 4.3 demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due.

Similar Executives

Showing few of many executives

DIRECTOR Since

Ravi BhoothalingamDr Reddys Laboratories Ltd
2000
Shlomo YanaiPerrigo Company Plc
N/A
Bruce CarterDr Reddys Laboratories Ltd
2008
Min TangOrigin Agritech Limited
2009
Alan GarberVertex Pharmaceuticals Incorpor
2017
Terrence KearneyVertex Pharmaceuticals Incorpor
2011
Laurie BrlasPerrigo Company Plc
2016
Marc TessierLavigneRegeneron Pharmaceuticals
2011
Lloyd CarneyVertex Pharmaceuticals Incorpor
2019
Michael BrownRegeneron Pharmaceuticals
1991
David BullockOrigin Agritech Limited
2015
Theodore SamuelsPerrigo Company Plc
2017
J MoreauDr Reddys Laboratories Ltd
2007
Charles BakerRegeneron Pharmaceuticals
N/A
Rolf ClassonPerrigo Company Plc
2017
George SingRegeneron Pharmaceuticals
1988
Jeffrey KindlerPerrigo Company Plc
2017
William YoungVertex Pharmaceuticals Incorpor
2014
Bradley AlfordPerrigo Company Plc
2017
Jacqualyn FousePerrigo Company Plc
2012
James KangOrigin Agritech Limited
2010

Entity Summary

Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. The company was founded in 1952 and is headquartered in Parsippany, New Jersey. Zoetis operates under Drug ManufacturersSpecialty Generic classification in USA and is traded on BATS Exchange. It employs 10000 people.Zoetis (ZTS) is traded on BATS Exchange in USA and employs 10,000 people.

Zoetis Leadership Team

Roman Trawicki, Executive Vice President and Presidentident of Global Manufacturing and Supply
Kristin Peck, Chief Executive Officer, Executive Vice President and Group President, U.S. Operations, Business Development and Strategy, Director
William Steere, Independent Director
Roxanne Lagano, Executive Vice President, Chief Human Resources Officer and Communications
Linda Rhodes, Independent Director
Frank DAmelio, Independent Director
Robert Scully, Independent Director
Clinton Lewis, Executive Vice President and Group President, International Operations, Commercial Development, Global Genetics, Aquatic Health and Human Medical Diagnostics
Stefan Weiskopf, Executive Vice President and Area President of the Asia Pacific, Australia and New Zealand
Sanjay Khosla, Independent Director
Paul Herendeen, CFO and Executive VP
Catherine Knupp, Executive Vice President, President - Research and Development
Michael McCallister, Non-Executive Independent Chairman of the Board
Paul Bisaro, Independent Director
Alejandro Bernal, Executive Vice President and Area President of the Europe, Africa and Middle East region
Willie Reed, Independent Director
Joyce Lee, Executive Vice President and Area President of the Canada and Latin America region
Glenn David, Chief Financial Officer, Executive Vice President
Sandra Beaty, Executive Vice President - Corporate Affairs
William Doyle, Director
Andrew Fenton, Executive Vice President and Chief Digital and Technology Officer
Gregory Norden, Independent Director
Louise Parent, Independent Director
Heidi Chen, Executive Vice President General Counsel, Corporate Secretary
Juan Alaix, Chief Executive Officer, Director

Stock Performance Indicators

Did you try this?

Run Insider Screener Now

   

Insider Screener

Find insiders across different sectors to evaluate their impact on performance
All  Next Launch Module

Also Currentnly Active

Purchased over 30 shares of
few hours ago
Traded for 80.1
Purchased over 300 shares of
few hours ago
Traded for 9.16
Purchased over 50 shares of
few hours ago
Traded for 58.39
See also Your Current Watchlist. Please also try Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.